Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides

Nature Medicine

Volumn 4, Issue 4, 1998, Pages 447-451

  Xu, Huaxi ^a   Gouras, Gunnar K ^b   Greenfield, Jeffrey P ^b   Vincent, Bruno ^a   Naslund, Jan ^a   Mazzarelli, Louis ^a   Fried, Gabriel ^c   Jovanovic, Jasmina N ^a   Seeger, Mary ^a   Relkin, Norman R ^b   Liao, Fang ^b   Checler, Frédéric ^d   Buxbaum, Joseph D ^a   Chait, Brian T ^a   Thinakaran, Gopal ^e   Sisodia, Sangram S ^e   Wang, Rong ^a   Greengard, Paul ^a   Gandy, Sam ^f  

^a ROCKEFELLER UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e DEPARTMENT OF PATHOLOGY   (United States)

^f NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ESTRADIOL; ESTROGEN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; EMBRYO; ESTROGEN THERAPY; FETUS; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; COCULTURE TECHNIQUES; EMBRYO; ESTRADIOL; FETUS; HUMANS; MICE; NEUROBLASTOMA; NEURONS; PEPTIDE FRAGMENTS; RATS; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031946864     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0498-447     Document Type: Article

References (35)

1. Glenner, G. & Wong, C. W. Alzheimer's disease: Initial report of the purification and characteristics of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 122, 885-890 (1984).
2. Masters, C. L. et al. Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4249 (1985).
3. Haass, C. Hung, A. Y., Schlossmacher, M. G., Teplow, D. B. & Selkoe, D. J. β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 3021-3024 (1993).
4. Haass, C. & Selkoe, D. J. Cellular processing of β-amyloid precursor protein and genesis of the amyloid-β peptide. Cell 75, 1039-42 (1993).
5. Jaffe, A. B., Toran-Allerand, C. D., Greengard, P. & Gandy, S. E. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J. Biol. Chem. 269, 13065-13068 (1994).
6. Wang, R., Sweeney, D., Gandy, S. E. & Sisodia, S. S. The profile of soluble amyloid β protein in cultured cell media. J. Biol. Chem. 271, 31894-31902 (1996).
7. Ausubel, F. M. et al. in Short Protocols in Molecular Biology, Second Edition, (John Wiley and Sons, New York, 1992).
8. Scheuner, D. et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-870 (1996).
9. Borchelt, D. R. et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013. (1996).
10. Duff, K. et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713 (1996).
11. Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Med. 3, 67-72 (1997).
12. Iwatsubo, T. et al. Visualization of Aβ 42(43) and Aβ 40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ 42(43). Neuron 13, 45-53 (1994).
13. Perez-Tur, J. et al. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7, 297-301 (1995).
14. Barelli, H. et al. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic and cerebral amyloid angiopathy cases. Mol. Med. 3, 695-707 (1997).
15. Kim, K. S. et al. Detection and quantitation of amyloid β-peptide with monoclonal antibodies. Neurosci. Res. Commun. 7, 113-122 (1990).
16. Lu, B., Yokoyama, M., Dreyfus, C. F., & Black, I.B. Depolarizing stimuli regulate nerve growth factor gene expression in cultured hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 88, 6289-6292 (1991).
17. Simons, M. et al. Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J. Neurosci. 16, 899-908 (1996).
18. Feingold, K. R., Galvin, L. A., Schambelan, M. & Sebastian, A. in Cecil's Essentials of Medicine (eds. Andreoli, T. E., Carpenter, C. C. J., Plum, F. & Smith, L. H.) 478 (W. B. Saunders Co., Philadelphia, 1990).
19. Tang, M. et al. Effect of oestrogen during menopause on risk and age of onset of Alzheimer's disease. Lancet 348, 429-432 (1996).
20. Luine, V. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 89, 484-490 (1985).
21. Woolley, C. S. & McEwen, B. S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol. 336, 293-306 (1993).
22. Woolley, C. S., Weiland, N. G., McEwen, B. S. & Schwartzkroin, P. A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci. 17, 1848-1859 (1997).
23. Toran-Allerand, C. D. The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant? Dev. Neurosci. 18, 36-48 (1996).
24. Behl, C., Widman, M., Trapp, T. & Holsboer, F. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473-182 (1995).
25. Larson, G. H. & Wise, P. M. Constitutive and regulated prolactin secretion: effects of estradiol. Biology of Reproduction. 50, 357-362 (1994).
26. Scammell, J. G., Burrage, T. C. & Dannies, P. S. Hormonal induction of secretory granules in a pituitary tumor cell line. Endocrinology 119, 1543-1548 (1986).
27. Xu, H. et al. Generation of Alzheimer β-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc. Natl. Acad. Sci. U.S.A. 94, 3748-3752 (1997).
28. Xu, H., Greengard, P. & Gandy, S. Regulated formation of Golgi secretory vesicles containing Alzheimer β-amyloid precursor protein. J. Biol. Chem. 270, 23243-23255 (1995).
29. Xu, H. Sweeney, D., Greengard, P. & Gandy, S. Metabolism of Alzheimer β-amyloid precursor protein: regulation by protein kinase A in intact cells and in a cell-free system. Proc. Natl. Acad. Sci. U.S.A. 93, 4081-4083 (1996).
30. Vincent, B., Beaudet, A., Dauch, P., Vincent, J.P., & Checler, F. Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differentiation, subcellular distribution, and secretion processes. J. Neurosci. 16, 5049-5059 (1996).
31. Buxbaum, J. D. et al. Processing of Alzheimer beta/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. U.S.A., 87, 6003-6006 (1990).
32. Thinakaran, G. et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190 (1996).
33. Evans, R. M. The steroid and thyroid hormone receptor superfamily. Science 240, 889-895 (1988).
34. Desdouits, F., Buxbaum, J. D., Desdouits-Magnen, J., Nairn, A. C. & Greengard, P. Amyloid β peptide formation in cell-free preparations. J. Biol. Chem. 271, 24670-24674 (1996).
35. Weidemann, A. et al. Identification, biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57, 115-126 (1989).